In This Article:
TORONTO, December 11, 2024--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and fiscal 2024 ended September 30, 2024, on Wednesday, December 18, 2024, prior to market open.
The Company will host a conference call to discuss its results with details as follows:
Date: Wednesday, December 18, 2024
Time: 8:00 am Eastern Time
To register for the conference call, please use this link:
https://registrations.events/direct/Q4I96766465
To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry. Registration is open through the live call.
To access the webcast:
https://events.q4inc.com/attendee/453820675
Participants will receive their details via email.
A replay of the webcast will be available within 24 hours after the conclusion of the call at https://www.organigram.ca/investors and will be archived for a period of 90 days following the call.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc. a licensed producer of cannabis, cannabis-derived products and cannabis infused edibles in Canada and Motif Labs Ltd., a licensed producer and leading brand house shaping Canada’s cannabis 2.0 market. Organigram is focused on producing high-quality cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend its global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis, Trailblazer, BOXHOT, DEBUNK, Rizzlers and Floe State. Organigram operates facilities in Moncton, New Brunswick, Lac-Supérieur, Quebec and Aylmer, Ontario where it has advanced CO2 and hydrocarbon extraction capabilities. The Company’s Winnipeg, Manitoba facility has dedicated edibles manufacturing while its fifth facility in London, Ontario provides a strategic location in Southwestern, Ontario that will be used as a distribution hub. The Company is regulated by Health Canada pursuant to the Cannabis Act and the Cannabis Regulations (Canada).